| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012963095 |
| P356 | DOI | 10.1038/NRNEUROL.2011.100 |
| P953 | full work available at URL | http://www.nature.com/articles/nrneurol.2011.100 |
| http://www.nature.com/articles/nrneurol.2011.100.pdf | ||
| https://doi.org/10.1038/nrneurol.2011.100 | ||
| https://europepmc.org/articles/PMC6980233 | ||
| https://europepmc.org/articles/pmc6980233?pdf=render | ||
| https://europepmc.org/articles/PMC6980233?pdf=render | ||
| P932 | PMC publication ID | 6980233 |
| P698 | PubMed publication ID | 21727940 |
| P5875 | ResearchGate publication ID | 51466100 |
| P2093 | author name string | Howard A. Fine | |
| Gregory Riddick | |||
| P2860 | cites work | Gene-Expression Profiles in Hereditary Breast Cancer | Q57240053 |
| The Cancer Biomedical Informatics Grid (caBIG): pioneering an expansive network of information and tools for collaborative cancer research | Q80994449 | ||
| Cancer Research | Q326097 | ||
| Science Signaling | Q7433604 | ||
| Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme | Q21183973 | ||
| Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma | Q24612429 | ||
| PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas | Q24615768 | ||
| Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility | Q24630647 | ||
| Identification of noninvasive imaging surrogates for brain tumor gene-expression modules | Q24647449 | ||
| An integrated genomic analysis of human glioblastoma multiforme | Q24648860 | ||
| Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| Online resources of cancer data: barriers, benefits and lessons | Q27010369 | ||
| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 | ||
| The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers | Q28115840 | ||
| Utilization of genomic signatures to identify phenotype-specific drugs | Q28476014 | ||
| Potential role of miRNAs and their inhibitors in glioma treatment | Q55463671 | ||
| The Many Functions of MicroRNAs in Glioblastoma | Q55463784 | ||
| Gene pathways and subnetworks distinguish between major glioma subtypes and elucidate potential underlying biology | Q55463869 | ||
| The Functional Genomics Experiment model (FuGE): an extensible framework for standards in functional genomics | Q56889083 | ||
| Exposing the cancer genome atlas as a SPARQL endpoint | Q28741373 | ||
| Genome-wide association study identifies five susceptibility loci for glioma | Q29614921 | ||
| Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Q29619677 | ||
| Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma | Q30014823 | ||
| Advances in the genetics of glioblastoma: are we reaching critical mass? | Q30426125 | ||
| A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery | Q30443764 | ||
| Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology | Q30756529 | ||
| Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations | Q30885944 | ||
| Gene expression patterns within cell lines are predictive of chemosensitivity | Q33318982 | ||
| Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation | Q33349703 | ||
| Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data | Q33368855 | ||
| Exploratory analysis of the copy number alterations in glioblastoma multiforme | Q33396458 | ||
| Automated network analysis identifies core pathways in glioblastoma | Q33532647 | ||
| CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterations | Q33551480 | ||
| The transcriptional network for mesenchymal transformation of brain tumours. | Q33572162 | ||
| Neuro-oncology: unmasking the multiforme in glioblastoma. | Q33597721 | ||
| GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes | Q33633443 | ||
| Allelic Selection of Amplicons in Glioblastoma Revealed by Combining Somatic and Germline Analysis | Q33687066 | ||
| Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship | Q33719798 | ||
| Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes | Q33754951 | ||
| Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma | Q33757859 | ||
| Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas | Q33759272 | ||
| Prediction of Associations between microRNAs and Gene Expression in Glioma Biology | Q33831813 | ||
| Chemosensitivity prediction by transcriptional profiling | Q33943845 | ||
| Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation. | Q33945989 | ||
| FastMEDUSA: a parallelized tool to infer gene regulatory networks | Q33950539 | ||
| Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM | Q33952887 | ||
| microRNA-451: A conditional switch controlling glioma cell proliferation and migration. | Q34127211 | ||
| A multigene predictor of outcome in glioblastoma. | Q34132666 | ||
| Predicting in vitro drug sensitivity using Random Forests | Q34480086 | ||
| Decoding global gene expression programs in liver cancer by noninvasive imaging | Q34630291 | ||
| Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy | Q34674928 | ||
| The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. | Q34976601 | ||
| A network model of a cooperative genetic landscape in brain tumors | Q34992306 | ||
| An integrative approach for in silico glioma research | Q35786441 | ||
| Breast cancer classification and prognosis based on gene expression profiles from a population-based study | Q35918291 | ||
| Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling | Q36288956 | ||
| Mining gene expression profiles: expression signatures as cancer phenotypes | Q36868498 | ||
| Models from experiments: combinatorial drug perturbations of cancer cells | Q36930517 | ||
| Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes | Q37101411 | ||
| Rembrandt: helping personalized medicine become a reality through integrative translational research | Q37103992 | ||
| Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions | Q37209222 | ||
| Molecular profiling in glioblastoma: prelude to personalized treatment | Q37350199 | ||
| MicroRNAs and glioblastoma; the stem cell connection | Q37517191 | ||
| Molecular epigenetics and genetics in neuro-oncology | Q37533620 | ||
| Oncogenic EGFR signaling networks in glioma | Q37593841 | ||
| The many roles of microRNAs in brain tumor biology | Q37665517 | ||
| Glioma pathophysiology: insights emerging from proteomics | Q37696535 | ||
| Glioma proteomics: status and perspectives. | Q37717824 | ||
| Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. | Q38305791 | ||
| Loss of ATM positively regulates the expression of hypoxia inducible factor 1 (HIF-1) through oxidative stress: Role in the physiopathology of the disease | Q39672967 | ||
| DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis | Q39847607 | ||
| Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas | Q40026836 | ||
| Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment. | Q40102545 | ||
| Primary glioblastomas express mesenchymal stem-like properties | Q40233143 | ||
| Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas | Q40383820 | ||
| TP53 promoter methylation in human gliomas | Q40396455 | ||
| Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. | Q40595717 | ||
| Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease | Q40781851 | ||
| Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. | Q41198732 | ||
| A novel algorithm for detecting differentially regulated paths based on gene set enrichment analysis | Q42115353 | ||
| A Developmental Taxonomy of Glioblastoma Defined and Maintained by MicroRNAs | Q42218583 | ||
| The Cancer Biomedical Informatics Grid (caBIGTM). | Q42611349 | ||
| In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma | Q42758535 | ||
| A network view of disease and compound screening | Q44111868 | ||
| Frequent epigenetic inactivation of the SLIT2 gene in gliomas | Q44526180 | ||
| Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression. | Q45340625 | ||
| Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. | Q45950089 | ||
| Why is cancer drug discovery so difficult? | Q45965493 | ||
| Revealing targeted therapy for human cancer by gene module maps. | Q45979161 | ||
| Gene expression profiling of gliomas strongly predicts survival | Q46043661 | ||
| Distinct transcription profiles of primary and secondary glioblastoma subgroups. | Q46259525 | ||
| Gene expression profiling identifies molecular subtypes of gliomas | Q47719947 | ||
| PTEN methylation and expression in glioblastomas | Q48232099 | ||
| Identification of molecular subtypes of glioblastoma by gene expression profiling | Q48332534 | ||
| Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. | Q48789680 | ||
| EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. | Q48945472 | ||
| A genetically tractable model of human glioma formation. | Q52542891 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | genomics | Q222046 |
| P304 | page(s) | 439-450 | |
| P577 | publication date | 2011-07-05 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Nature Reviews Neurology | Q2079285 |
| P1476 | title | Integration and analysis of genome-scale data from gliomas | |
| P478 | volume | 7 |
| Q38935555 | An in silico screen links gene expression signatures to drug response in glioblastoma stem cells |
| Q48559378 | CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR. |
| Q58751776 | Casein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival |
| Q41000308 | Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization |
| Q37019743 | Chromosomal Aberrations in Canine Gliomas Define Candidate Genes and Common Pathways in Dogs and Humans |
| Q30792298 | Deciphering global signal features of high-throughput array data from cancers |
| Q34406374 | Distinct and Competitive Regulatory Patterns of Tumor Suppressor Genes and Oncogenes in Ovarian Cancer |
| Q98568592 | E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression |
| Q38199643 | EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy. |
| Q35914897 | Emerging insights into the molecular and cellular basis of glioblastoma |
| Q24273294 | Epigenetic pathways and glioblastoma treatment |
| Q37287987 | Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches |
| Q49952146 | H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma |
| Q35781376 | HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation |
| Q36562247 | Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance |
| Q34624405 | Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis |
| Q35624037 | Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data |
| Q90323312 | Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment |
| Q37734374 | Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes. |
| Q43507825 | LncRNA HSP90AA1-IT1 promotes gliomas by targeting miR-885-5p-CDK2 pathway |
| Q36087352 | Mammalian Ste20-like kinase 4 promotes pituitary cell proliferation and survival under hypoxia |
| Q37279893 | Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. |
| Q37728696 | Migfilin sensitizes cisplatin-induced apoptosis in human glioma cells in vitro |
| Q104064418 | Modelling genetic mosaicism of neurodevelopmental disorders in vivo by a Cre-amplifying fluorescent reporter |
| Q35775831 | Molecular Profiling of a Rare Rosette-Forming Glioneuronal Tumor Arising in the Spinal Cord |
| Q52091959 | NF-κB Signalling in Glioblastoma |
| Q24631889 | Neural stem cells: brain building blocks and beyond |
| Q30459213 | Neurofibromatosis Type 2 Tumor Suppressor Protein, NF2, Induces Proteasome-Mediated Degradation of JC Virus T-Antigen in Human Glioblastoma |
| Q42111511 | Nucleic Acids in Human Glioma Treatment: Innovative Approaches and Recent Results |
| Q59793764 | Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins |
| Q36906753 | Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth. |
| Q38898532 | Proteomic screening and identification of microRNA-128 targets in glioma cells |
| Q42367453 | Pushing the limits of glioma resection using electrophysiologic brain mapping |
| Q36797902 | Role of MicroRNAs in Malignant Glioma |
| Q96135262 | Survival Risk Prediction Models of Gliomas Based on IDH and 1p/19q |
| Q91329830 | TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis |
| Q36514117 | Targeting NF-κB in glioblastoma: A therapeutic approach |
| Q37392691 | The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathway |
| Q64101370 | The landscape of the mesenchymal signature in brain tumours |
| Q38239173 | Towards developing biomarkers for glioblastoma multiforme: a proteomics view |
| Q35591421 | Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV |
| Q50541983 | Using the QAPgrid Visualization Approach for Biomarker Identification of Cell-Specific Transcriptomic Signatures. |
| Q47978735 | miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients |
| Q57801751 | miR-29s function as tumor suppressors in gliomas by targeting TRAF4 and predict patient prognosis |
Search more.